Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
CancerSurvivalRates.com is a survival-rate statistics lookup website for cancer patients, families, and medical professionals. Based on the crawled text, it covers more than 30 cancer types, claims to have been used by over 750,000 users since 2020, and says it is trusted by patients, families, and doctors. The site clearly states that its estimates are based on the U.S. National Cancer Institute’s SEER database, using cancer case data from 2004–2021. The page indicates that it was last updated in January 2026.
Functionally, the site is mainly used to look up survival-rate statistics for different cancer types, and it may offer some level of personalized estimation workflow. Its biggest strength is transparency around data sources: it uses the SEER database, which is important for medical statistics products. The site also lists a medical advisory and team lineup consisting of oncologists, epidemiologists, and the founding team, including people affiliated with UC San Diego, University of Sydney, UC Irvine, and other institutions. It is important to note that the site explicitly states it does not provide medical advice and is for informational purposes only; diagnosis and treatment decisions should still be discussed with qualified medical professionals.
By developer-tool standards, the site provides clearly insufficient information. The crawled content does not mention supported programming languages, frameworks, APIs, SDKs, webhooks, an integration marketplace, a CLI, deployment documentation, or self-hosting options, nor does it describe any open-source repository. Therefore, it should not be regarded as a tool that can be directly embedded into a development workflow. It is closer to an end-user-facing medical data lookup service. If developers want to integrate cancer statistics into an application, the current text does not demonstrate that the site offers a machine-readable interface or a commercial licensing model.
The content does not disclose a pricing model, subscription plans, payment methods, or enterprise services. Its advantages are broad cancer-type coverage, stated data sources, a transparent medical advisory lineup, and appropriate compliance awareness through its “not medical advice” disclaimer. Its drawbacks are the lack of key product information such as pricing, documentation, API access, self-hosting, and an integration ecosystem. In addition, because SEER data is primarily based on the U.S. population, it should be used cautiously when applied directly to patients in China or other regions.
Access from mainland China cannot be determined from the text and should be marked as unknown. For general patient education, users can refer to public materials from hospitals or authoritative medical institutions. For developers who need data capabilities, it may be better to study the official NCI SEER data resources directly or use other public medical databases. Overall, CancerSurvivalRates.com is suitable for patients, families, and doctors as a statistical information reference, but it is not an ideal first choice for developer-tool procurement or technical integration.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on cancersurvivalrates.com official site.
cancersurvivalrates.com is an United States Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach cancersurvivalrates.com directly.